IR Ingersoll Rand Inc.
General Industrial Machinery & Equipment · NYSE · SEC CIK 1699150 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.0%
TTM net income YoY154.1%
TTM EPS YoY161.5%
Revenue 3-yr CAGR6.4%
Net income 3-yr CAGR21.8%
Margins
Gross margin43.1%
Operating margin22.9%
Net margin17.2%
FCF margin18.8%
EBITDA margin29.7%
Returns
ROE13.4%
ROA7.5%
ROIC (approx.)11.5%
Asset turnover0.44x
Leverage & solvency
Liabilities / assets43.2%
Debt / equity0.45x
Current ratio1.69x
Interest coverage7.23x
Cash quality & payout
Operating cash flow / net income1.19x
Accruals ratio-1.4%
Payout ratio2.2%
Capex / revenue1.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $7.65B | $7.24B |
| Cost of revenue | $4.31B | $4.07B |
| Gross profit | $3.34B | $3.17B |
| R&D expense | $114.30M | $116.60M |
| SG&A expense | $1.44B | $1.34B |
| Operating income | $1.14B | $1.30B |
| Interest expense | $253.90M | $213.20M |
| Pretax income | $935.30M | $1.13B |
| Income tax | $219.40M | $262.50M |
| Net income | $581.40M | $838.60M |
| EBITDA | $1.65B | $1.78B |
| EPS (basic) | 1.46 | 2.08 |
| EPS (diluted) | 1.45 | 2.06 |
| Weighted avg. shares (diluted) | 401.00M | 407.20M |
| Balance sheet | ||
| Cash & equivalents | $1.25B | $1.54B |
| Receivables | $1.52B | $1.34B |
| Inventory | $1.17B | $1.05B |
| Current assets | $4.25B | $4.16B |
| PP&E, net | $930.30M | $842.10M |
| Goodwill | $8.48B | $8.15B |
| Intangibles | $4.24B | $4.37B |
| Total assets | $18.30B | $18.01B |
| Current liabilities | $2.07B | $1.82B |
| Short-term debt | $1.40M | $3.10M |
| Long-term debt | $4.78B | $4.75B |
| Total debt | $4.78B | $4.76B |
| Total liabilities | $8.14B | $7.76B |
| Shareholders' equity | $10.09B | $10.18B |
| Net debt | $3.54B | $3.22B |
| Shares outstanding | 391.12M | 402.88M |
| Cash flow statement | ||
| Operating cash flow | $1.36B | $1.40B |
| Capital expenditure | $135.60M | $149.10M |
| Free cash flow | $1.22B | $1.25B |
| Investing cash flow | -$660.60M | -$3.11B |
| Financing cash flow | -$1.05B | $1.71B |
| Depreciation & amortization | $505.80M | $482.00M |
| Stock-based compensation | $53.00M | $58.80M |
| Dividends paid | $31.80M | $32.30M |
| Share buybacks | $1.02B | $260.70M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.